
Talar Derashodian
@talard
Radiation Oncologist, Brachytherapist, teacher, part of Curitherapies’ team
ID: 121969264
11-03-2010 05:17:22
147 Tweet
77 Followers
91 Following



How to attract trainees in brachytherapy? What an excellent talk by Mark Corkum MD, MSc, FRCPC, DRCPSC Curietherapi.es! #Thisisbrachytherapy #Curietherapies2022







Yujing Yujing Zou and Fabian Fabian Svahn enjoying themselves at the Curietherapi.es! Future of #brachytherapy is bright! #curietherapies2022 McGill Medical Physics #Thisisbrachytherapy


Josh Yamada and Stefanie Corradini 🌟 discussing ways to move brachytherapy forward! #Curietherapies2022 #brachytherapy

Thank you Marjory Jolicoeur and Curietherapi.es for the kind invitation to present our experience on #brachytherapy LMU Radiation Oncology in collaboration with LMUradiology at #curietherpies2022! it was a pleasure to visit you in Montreal 🇨🇦


Dr Marjory Jolicoeur Marjory Jolicoeur shared her experience of 2-fractions in one day HDR monotherapy for prostate cancer. #curietherapies2022 #brachytherapy


A great conclusin to a great meeting with Dr Cynthia Menard discussing focal prostate brachytherapy Curietherapi.es #Curietherapies2022

Happy to share our Cleveland Clinic Urology findings: high risk Decipher scores are associated with the presence of Cribriform either alone or in combination with Intraductal Carcinoma features at RP. authors.elsevier.com/a/1fA8y8Yy0LMx…


Thank you for 20 years of Leadership and Support #HimuLukka #GUROC22 And welcome to the new co-chairs Scott Morgan Dr. Tamim Niazi




Gert De Meerleer reminds us that Moses was given a 11th commandment in Mount Sinaï.. Luckily, 3500 years later, Shankar Siva and other #rccsbrt prophets disobeyed and proved that radiotherapy could cure localized RCC patients. GFRU #GFRU24 #renalcancer #FastrackII


Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in European Urology sciencedirect.com/science/articl… The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between
